Modeling human liver biology using stem cell-derived hepatocytes

International Journal of Molecular Sciences

Volumn 14, Issue 11, 2013, Pages 22011-22021

  Sun, Pingnan ^a,b,c   Zhou, Xiaoling ^a,b,c   Farnworth, Sarah L ^b   Patel, Arvind H ^c   Hay, David C ^b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

Author keywords

Cell based models; Drug metabolism; Liver disease; Stem cell; Stem cell derived hepatocytes

Indexed keywords

CYTOCHROME P450;

ALCOHOL LIVER DISEASE; BIOLOGY; BLOOD CELL; CELL CLONE; CELL DIFFERENTIATION; CELL LINE; DRUG CONJUGATION; DRUG IDENTIFICATION; DRUG INDUSTRY; DRUG METABOLISM; DRUG TRANSPORT; EMBRYONIC STEM CELL; GENETIC DISORDER; HEPATITIS; HUMAN; IN VITRO STUDY; LIVER BIOLOGY; LIVER CELL; LIVER DISEASE; LIVER TOXICITY; MOLECULAR MODEL; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; SOMATIC CELL; STEM CELL; VIRUS ENTRY; VIRUS INFECTION; VIRUS REPLICATION;

CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HEPATOCYTES; HUMANS; LIVER; LIVER DISEASES;

EID: 84887203519     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141122011     Document Type: Review

References (65)

1. Kmiec, Z. Cooperation of liver cells in health and disease. Adv. Anat. Embryol. Cell Biol. 2001, 161, 1-151.
2. Espanol-Suner, R.; Carpentier, R.; van Hul, N.; Legry, V.; Achouri, Y.; Cordi, S.; Jacquemin, P.; Lemaigre, F.; Leclercq, I. A. Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. Gastroenterology 2012, doi: 10. 1053/j. gastro. 2012. 08. 024.
3. Thiele, G. M.; Klassen, L. W.; Tuma, D. J. Formation and immunological properties of aldehyde-derived protein adducts following alcohol consumption. Methods Mol. Biol. 2008, 447, 235-257.
4. Lecluyse, E. L.; Alexandre, E. Isolation and culture of primary hepatocytes from resected human liver tissue. Methods Mol. Biol. 2010, 640, 57-82.
5. Gomez-Lechon, M. J.; Donato, M. T.; Castell, J. V.; Jover, R. Human hepatocytes in primary culture: The choice to investigate drug metabolism in man. Curr. Drug Metab. 2004, 5, 443-462.
6. Hewitt, N. J.; Lechon, M. J.; Houston, J. B.; Hallifax, D.; Brown, H. S.; Maurel, P.; Kenna, J. G.; Gustavsson, L.; Lohmann, C.; Skonberg, C.; et al. Primary hepatocytes: Current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab. Rev. 2007, 39, 159-234.
7. Donato, M. T.; Lahoz, A.; Castell, J. V.; Gomez-Lechon, M. J. Cell lines: A tool for in vitro drug metabolism studies. Curr. Drug Metab. 2008, 9, 1-11.
8. Meylan, E.; Curran, J.; Hofmann, K.; Moradpour, D.; Binder, M.; Bartenschlager, R.; Tschopp, J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437, 1167-1172.
9. Jover, R.; Bort, R.; Gomez-Lechon, M. J.; Castell, J. V. Re-expression of C/EBP alpha induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells. FEBS Lett. 1998, 431, 227-230.
10. Schrem, H.; Klempnauer, J.; Borlak, J. Liver-enriched transcription factors in liver function and development. Part II: The C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacol. Rev. 2004, 56, 291-330.
11. Wong, N.; Lai, P.; Pang, E.; Leung, T. W.; Lau, J. W.; Johnson, P. J. A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping. Hepatology 2000, 32, 1060-1068.
12. Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S.; Jones, J. M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282, 1145-1147.
13. Reubinoff, B. E.; Pera, M. F.; Fong, C. Y.; Trounson, A.; Bongso, A. Embryonic stem cell lines from human blastocysts: Somatic differentiation in vitro. Nat. Biotechnol. 2000, 18, 399-404.
14. Zhou, W.; Hannoun, Z.; Jaffray, E.; Medine, C. N.; Black, J. R.; Greenhough, S.; Zhu, L.; Ross, J. A.; Forbes, S.; Wilmut, I.; et al. SUMOylation of HNF4α regulates protein stability and hepatocyte function. J. Cell Sci. 2012, 125, 3630-3635.
15. Lavon, N.; Benvenisty, N. Study of hepatocyte differentiation using embryonic stem cells. J. Cell. Biochem. 2005, 96, 1193-1202.
16. Basma, H.; Soto-Gutierrez, A.; Yannam, G. R.; Liu, L.; Ito, R.; Yamamoto, T.; Ellis, E.; Carson, S. D.; Sato, S.; Chen, Y.; et al. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 2009, 136, 990-999.
17. Duan, Y.; Catana, A.; Meng, Y.; Yamamoto, N.; He, S.; Gupta, S.; Gambhir, S. S.; Zern, M. A. Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo. Stem Cells 2007, 25, 3058-3068.
18. Hay, D. C.; Fletcher, J.; Payne, C.; Terrace, J. D.; Gallagher, R. C.; Snoeys, J.; Black, J. R.; Wojtacha, D.; Samuel, K.; Hannoun, Z.; et al. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc. Natl. Acad. Sci. USA 2008, 105, 12301-12306.
19. Itskovitz-Eldor, J.; Schuldiner, M.; Karsenti, D.; Eden, A.; Yanuka, O.; Amit, M.; Soreq, H.; Benvenisty, N. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol. Med. 2000, 6, 88-95.
20. Imamura, T.; Cui, L.; Teng, R.; Johkura, K.; Okouchi, Y.; Asanuma, K.; Ogiwara, N.; Sasaki, K. Embryonic stem cell-derived embryoid bodies in three-dimensional culture system form hepatocyte-like cells in vitro and in vivo. Tissue Eng. 2004, 10, 1716-1724.
21. Vosough, M.; Omidinia, E.; Kadivar, M.; Shokrgozar, M. A.; Pournasr, B.; Aghdami, N.; Baharvand, H. Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture. Stem Cells Dev. 2013, 22, 2693-2705.
22. Hay, D. C.; Zhao, D.; Ross, A.; Mandalam, R.; Lebkowski, J.; Cui, W. Direct differentiation of human embryonic stem cells to hepatocyte-like cells exhibiting functional activities. Cloning Stem Cells 2007, 9, 51-62.
23. Agarwal, S.; Holton, K. L.; Lanza, R. Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells 2008, 26, 1117-1127.
24. Hannoun, Z.; Fletcher, J.; Greenhough, S.; Medine, C.; Samuel, K.; Sharma, R.; Pryde, A.; Black, J. R.; Ross, J. A.; Wilmut, I.; et al. The comparison between conditioned media and serum-free media in human embryonic stem cell culture and differentiation. Cell Reprogram 2010, 12, 133-140.
25. Hay, D. C.; Pernagallo, S.; Diaz-Mochon, J. J.; Medine, C. N.; Greenhough, S.; Hannoun, Z.; Schrader, J.; Black, J. R.; Fletcher, J.; Dalgetty, D.; et al. Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism. Stem Cell Res. 2011, 6, 92-102.
26. Hay, D. C. Rapid and scalable human stem cell differentiation: Now in 3D. Stem Cells Dev. 2013, 22, 2691-2692.
27. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663-676.
28. Dalgetty, D. M.; Medine, C. N.; Iredale, J. P.; Hay, D. C. Progress and future challenges in stem cell-derived liver technologies. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 297, G241-G248.
29. Sullivan, G. J.; Hay, D. C.; Park, I. H.; Fletcher, J.; Hannoun, Z.; Payne, C. M.; Dalgetty, D.; Black, J. R.; Ross, J. A.; Samuel, K.; et al. Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology 2010, 51, 329-335.
30. Kajiwara, M.; Aoi, T.; Okita, K.; Takahashi, R.; Inoue, H.; Takayama, N.; Endo, H.; Eto, K.; Toguchida, J.; Uemoto, S.; et al. Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc. Natl. Acad. Sci. USA 2012, 109, 12538-12543.
31. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131, 861-872.
32. Yu, J.; Vodyanik, M. A.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J. L.; Tian, S.; Nie, J.; Jonsdottir, G. A.; Ruotti, V.; Stewart, R.; et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318, 1917-1920.
33. Huang, P.; He, Z.; Ji, S.; Sun, H.; Xiang, D.; Liu, C.; Hu, Y.; Wang, X.; Hui, L. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 2011, 475, 386-389.
34. Sekiya, S.; Suzuki, A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 2011, 475, 390-393.
35. Yu, B.; He, Z.-Y.; You, P.; Han, Q.-W.; Xiang, D.; Chen, F.; Wang, M.-J.; Liu, C.-C.; Lin, X.-W.; Borjigin, U. Reprogramming fibroblasts into bipotential hepatic stem cells by defined factors. Cell Stem Cell 2013, 13, 328-340.
36. Vierbuchen, T.; Ostermeier, A.; Pang, Z. P.; Kokubu, Y.; Sudhof, T. C.; Wernig, M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463, 1035-1041.
37. Ieda, M.; Fu, J. D.; Delgado-Olguin, P.; Vedantham, V.; Hayashi, Y.; Bruneau, B. G.; Srivastava, D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142, 375-386.
38. Szabo, E.; Rampalli, S.; Risueno, R. M.; Schnerch, A.; Mitchell, R.; Fiebig-Comyn, A.; Levadoux-Martin, M.; Bhatia, M. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010, 468, 521-526.
39. Kola, I.; Landis, J. Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 2004, 3, 711-715.
40. Orloff, J.; Douglas, F.; Pinheiro, J.; Levinson, S.; Branson, M.; Chaturvedi, P.; Ette, E.; Gallo, P.; Hirsch, G.; Mehta, C.; et al. The future of drug development: Advancing clinical trial design. Nat. Rev. Drug Discov. 2009, 8, 949-957.
41. Gomez-Lechon, M. J.; Lahoz, A.; Gombau, L.; Castell, J. V.; Donato, M. T. In vitro evaluation of potential hepatotoxicity induced by drugs. Curr. Pharm. Des. 2010, 16, 1963-1977.
42. Baranczewski, P.; Stanczak, A.; Sundberg, K.; Svensson, R.; Wallin, A.; Jansson, J.; Garberg, P.; Postlind, H. Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. Pharmacol. Rep. 2006, 58, 453-472.
43. Medine, C. N.; Lucendo-Villarin, B.; Storck, C.; Wang, F.; Szkolnicka, D.; Khan, F.; Pernagallo, S.; Black, J. R.; Marriage, H. M.; Ross, J. A.; et al. Developing high-fidelity hepatotoxicity models from pluripotent stem cells. Stem Cells Transl. Med. 2013, 2, 505-509.
44. Guengerich, F. P. Cytochrome p450 and chemical toxicology. Chem. Res. Toxicol. 2008, 21, 70-83.
45. Rodrigues, A. D. Integrated cytochrome P450 reaction phenotyping: Attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes. Biochem. Pharmacol. 1999, 57, 465-480.
46. Thummel, K. E.; Wilkinson, G. R. In vitro and in vivo drug interactions involving human CYP3A. Annu. Rev. Pharmacol. Toxicol. 1998, 38, 389-430.
47. Giacomini, K. M.; Huang, S. M.; Tweedie, D. J.; Benet, L. Z.; Brouwer, K. L.; Chu, X.; Dahlin, A.; Evers, R.; Fischer, V.; Hillgren, K. M.; et al. Membrane transporters in drug development. Nat. Rev. Drug Discov. 2010, 9, 215-236.
48. Greenhough, S.; Medine, C. N.; Hay, D. C. Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening. Toxicology 2010, 278, 250-255.
49. Yildirimman, R.; Brolen, G.; Vilardell, M.; Eriksson, G.; Synnergren, J.; Gmuender, H.; Kamburov, A.; Ingelman-Sundberg, M.; Castell, J.; Lahoz, A.; et al. Human embryonic stem cell derived hepatocyte-like cells as a tool for in vitro hazard assessment of chemical carcinogenicity. Toxicol. Sci. 2011, 124, 278-290.
50. Ghodsizadeh, A.; Taei, A.; Totonchi, M.; Seifinejad, A.; Gourabi, H.; Pournasr, B.; Aghdami, N.; Malekzadeh, R.; Almadani, N.; Salekdeh, G. H.; et al. Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells. Stem Cell Rev. 2010, 6, 622-632.
51. Rashid, S. T.; Corbineau, S.; Hannan, N.; Marciniak, S. J.; Miranda, E.; Alexander, G.; Huang-Doran, I.; Griffin, J.; Ahrlund-Richter, L.; Skepper, J.; et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J. Clin. Investig. 2010, 120, 3127-3136.
52. Zhang, S.; Chen, S.; Li, W.; Guo, X.; Zhao, P.; Xu, J.; Chen, Y.; Pan, Q.; Liu, X.; Zychlinski, D.; et al. Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin. Hum. Mol. Genet. 2011, 20, 3176-3187.
53. Wu, X.; Robotham, J. M.; Lee, E.; Dalton, S.; Kneteman, N. M.; Gilbert, D. M.; Tang, H. Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PLoS Pathog. 2012, 8, e1002617.
54. Roelandt, P.; Obeid, S.; Paeshuyse, J.; Vanhove, J.; van Lommel, A.; Nahmias, Y.; Nevens, F.; Neyts, J.; Verfaillie, C. M. Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. J. Hepatol. 2012, 57, 246-251.
55. Schwartz, R. E.; Trehan, K.; Andrus, L.; Sheahan, T. P.; Ploss, A.; Duncan, S. A.; Rice, C. M.; Bhatia, S. N. Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc. Natl. Acad. Sci. USA 2012, 109, 2544-2548.
56. Ganem, D.; Prince, A. M. Hepatitis B virus infection--natural history and clinical consequences. N. Engl. J. Med. 2004, 350, 1118-1129.
57. Paganelli, M.; Dallmeier, K.; Nyabi, O.; Scheers, I.; Kabamba, B.; Neyts, J.; Goubau, P.; Najimi, M.; Sokal, E. M. Differentiated umbilical cord matrix stem cells as a newin vitromodel to study early events during hepatitis B virus infection. Hepatology 2013, 57, 59-69.
58. Taylor, J. M. Hepatitis delta virus. Virology 2006, 344, 71-76.
59. Yan, H.; Zhong, G.; Xu, G.; He, W.; Jing, Z.; Gao, Z.; Huang, Y.; Qi, Y.; Peng, B.; Wang, H.; et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 2012, 1, e00049.
60. O'Shea, R. S.; Dasarathy, S.; McCullough, A. J. Alcoholic liver disease. Hepatology 2010, 51, 307-328.
61. D'Souza El-Guindy, N. B.; Kovacs, E. J.; de Witte, P.; Spies, C.; Littleton, J. M.; de Villiers, W. J.; Lott, A. J.; Plackett, T. P.; Lanzke, N.; Meadows, G. G. Laboratory models available to study alcohol-induced organ damage and immune variations: Choosing the appropriate model. Alcohol. Clin. Exp. Res. 2010, 34, 1489-1511.
62. Seitz, H. K.; Stickel, F. Acetaldehyde as an underestimated risk factor for cancer development: Role of genetics in ethanol metabolism. Genes Nutr. 2010, 5, 121-128.
63. Pal, R.; Mamidi, M. K.; Das, A. K.; Gupta, P. K.; Bhonde, R. A simple and economical route to generate functional hepatocyte-like cells from hESCs and their application in evaluating alcohol induced liver damage. J. Cell. Biochem. 2012, 113, 19-30.
64. Szkolnicka, D.; Zhou, W.; Lucendo-Villarin, B.; Hay, D. C. Pluripotent stem cell-derived hepatocytes: Potential and challenges in pharmacology. Annu. Rev. Pharmacol. Toxicol. 2013, 53, 147-159.
65. Szkolnicka, D.; Farnworth, S.; Lucendo-Villarin, B.; Storck, C.; Zhou, W.; Iredale, J. P.; Flint, O.; Hay, D. C. Accurate prediction of potential liver injury using stem cell derived populations. Stem Cells Transl. Med. 2014, accepted for publication.